载脂蛋白E相关肾小球疾病
本文综述了由载脂蛋白E(apoE)突变导致的肾小球疾病,包括apoE2纯合子肾小球病和脂蛋白肾病(LPG)。apoE2纯合子肾小球病以泡沫细胞浸润和偶见非层状脂蛋白血栓为特征,而apoE Toyonaka突变可导致非免疫性膜性肾病样改变。LPG与杂合apoE突变相关,以层状脂蛋白血栓为特征,其机制涉及热力学不稳定和apoE聚集。
要点
- apoE2纯合子肾小球病表现为泡沫细胞浸润和偶见非层状脂蛋白血栓。
- apoE Toyonaka突变可导致非免疫性膜性肾病样改变,伴apoE沉积。
- LPG与杂合apoE突变相关,以层状脂蛋白血栓为特征,无泡沫细胞。
核心结论
- 多种apoE突变通过不同机制导致特征性肾小球疾病,巨噬细胞摄取脂蛋白形成泡沫细胞参与apoE2纯合子肾小球病,其功能障碍可能促进LPG中脂蛋白血栓形成。
研究设计与样本
- 本文为综述,未报告检索范围。
主要发现
- apoE2纯合子肾小球病见于apoE2/2纯合子个体,组织学特征为肾小球硬化伴明显泡沫细胞浸润,偶见非层状脂蛋白血栓。
- 近年报道数例apoE Toyonaka(Ser197Cys)合并apoE2/2纯合子病例,肾小球呈现非免疫性膜性肾病样特征,串联质谱鉴定到apoE沉积。
- LPG主要与低密度脂蛋白受体结合位点周围的杂合apoE突变相关,组织学特征为层状脂蛋白血栓,无泡沫细胞。
- 近期研究提示LPG可由热力学不稳定、疏水表面暴露及螺旋区突变残基不相容导致的apoE聚集所诱导。
- apoE5可能通过高脂蛋白血症在LPG和脂质诱导的肾脏疾病中起支持作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Of the glomerular disorders that occur due to apolipoprotein E (apoE) mutations, apoE2 homozygote glomerulopathy and lipoprotein glomerulopathy (LPG) have been characterized. ApoE2 homozygote glomerulopathy has been found in individuals expressing homozygous apoE2/2. This was characterized histologically by glomerulosclerosis with marked infiltration of foam cells derived from macrophages, and occasionally with non-lamellated lipoprotein thrombi. Recently, several cases of apoE Toyonaka (Ser197Cys) combined with homozygous apoE2/2 have been reported, in which non-immune membranous nephropathy-like features were observed in glomeruli. Interestingly, in these cases, apoE accumulation was identified by tandem mass spectrometry. Therefore, it is speculated that these findings may arise from apoE molecules without lipids, which result from hinge damage by apoE Toyonaka and may cross the glomerular basement membrane as small molecules. LPG is primarily associated with heterozygous apoE mutations surrounding the low-density lipoprotein-receptor binding site, and it is histologically characterized by lamellated lipoprotein thrombi that lack foam cells. Recent studies have suggested that LPG can be induced by thermodynamic destabilization, hydrophobic surface exposure, and the aggregation of apoE resulting from the incompatibility of apoE mutated residues within helical regions. Additionally, apoE5 may play a supporting role in the development of LPG and in lipid-induced kidney diseases via hyperlipoproteinemia. Thus, it is interesting that many apoE mutations contribute to characteristic glomerular disorders through various mechanisms. In particular, macrophages may uptake lipoproteins into the cytoplasm and contribute to the development of apoE2 homozygote glomerulopathy as foam cells, and their dysfunction may contribute to the accumulation of lipoproteins in the glomerulus, causing lipoprotein thrombi in LPG.
引用
- Saito T, Matsunaga A, Fukunaga M, et al. Apolipoprotein E-related glomerular disorders. Kidney Int. 2019. PMID: 31874799. doi:10.1016/j.kint.2019.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。